1 World Health Organisation. Neurological Disorders: Public Health Challenges. Switzerland: World Health Organisation; 2006.
2 Feigin VL, Nichols E, Alam T, Bannick MS, Beghi E, Blake N, et al. Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18(5):459–80.
3 Freeman WD, Vatz KA, Griggs RC, Pedley T. Clinical implications for neurology. Neurology. 2013;81:479–86.
4 Morrish PK. Inadequate neurology services undermine patient care in the UK. BMJ. 2015;350(June):1–2.
5 Morrish P. What is happening to English neurology: an update. Clin Med. 2013;11(1):101–2.
6 National Audit Office. Services for people with neurological conditions. 2011.
7 Smith R, Rennie D. Evidence-based medicine - An oral history. JAMA - J Am Med Assoc. 2014;311(4):365–7.
8 Zuiderent-Jerak T, Forland F, Macbeth F. Guidelines should reflect all knowledge, not just clinical trials. BMJ. 2012;345(oct054):e6702–e6702.
9 Sackett DL, Rosenberg WMC, Gray JAM, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isnt. BMJ. 1996;312(7023):71–2.
10 Nie X, Peng X. The reporting of studies conducted using observational routinely-collected health data (RECORD) statement. Chinese J Evidence-Based Med. 2017;17(4):475–87.
11 Kwakkenbos L, Imran M, McCord KA, Sampson M, Fröbert O, Gale C, et al. Protocol for a scoping review to support development of a CONSORT extension for randomised controlled trials using cohorts and routinely collected health data. BMJ Open. 2018;8(8):1–5.
12 Casey JA, Schwartz B, Stewart W, Adler NE. Using Electronic Health Records for Population Health Research: A Review of Methods and Applications. Annu. Rev. Public Health. 2016;37:61–81
13 Stone J, Carson A, Duncan R, Roberts R, Warlow C, Hibberd C, et al. Who is referred to neurology clinics? - The diagnoses made in 3781 new patients. Clin Neurol Neurosurg. 2010;112(9):747–51.
14 Bateman D. The future of neurology services in the UK. Pract Neurol. 2011;11(3):134–5.
15 Tankersley A. Tolerability of intravenously administered immune globulin in the home setting. Value in Health. 2009;12(3):A132–A132.
16 Sommer C, Brunnert M, Fricke S, Wallenstein L, Baehr M, Langebrake C. Evaluation of pharmacoeconomic interventions in neurological patients treated with immunoglobulins. Eur J Hosp Pharm Sci Pract. 2014 Mar 1;21(Suppl 1):A55 LP-A56.
17 Singh V, Darger B, Madhok D, Diaz M, Wybourn C. Prevalence of neurologic emergencies in patients presenting as trauma activations to an urban level I trauma center. Neurocrit Care. 2017;27(2 Supplement 1):S292
18 Diaz M, Darger B, Wybourn C, Singh V, Madhok D. Neurologic emergencies presenting as trauma activations to a level i trauma center. Acad Emerg Med. 2018;25(Supplement 1):S159.
19 Pula J, Shiloach M, Heunisch C. Medication Reconciliation in a Neuro-Ophthalmology Clinic (P1.360). Neurology. 2016 Apr 5;86(16 Supplement):P1.360.
20 Ho C, Guilcher SJT, McKenzie N, Mouneimne M, Williams A, Voth J, et al. Validation of Algorithm to Identify Persons with Non-traumatic Spinal Cord Dysfunction in Canada Using Administrative Health Data. Top Spinal Cord Inj Rehabil. 2017;23(4):333–42.
21 Chase HS, Mitrani LR, Lu GG, Fulgieri DJ. Early recognition of multiple sclerosis using natural language processing of the electronic health record. BMC Med Inform Decis Mak. 2017;17(1):24.
22 Kestenbaum M, Robakis D, Ford B, Alcalay RN, Louis ED. Clinical characteristics of patients with parkinson’s disease and essential tremor undergoing deep brain stimulation surgery at columbia university medical center, 2009–2014. Israel Medical Association Journal. 2016;18(7):386–90.
23 Modi SY, Dharaiya D, Katramados AM, Mitsias P. Predictors of Prolonged Hospital Stay in Status Migrainosus. The Neurohospitalist. 2016;6(4):141–6.
24 Bishop DVM. Which neurodevelopmental disorders get researched and why? PLoS One. 2010;5(11).
25 Al-Shahi R, Will RG, Warlow CP. Amount of research interest in rare and common neurological conditions: Bibliometric study. Br Med J. 2001;323(7327):1461–2.
26 Obermeyer Z, Emanuel EJ. Predicting the Future-Big Data, Machine Learning, and Clinical Medicine HHS Public Access. N Engl J Med. 2016;375(13):1216–9.
27 Siciliani L, Moran V, Borowitz M. Measuring and comparing health care waiting times in OECD countries. Health Policy. 2014;118(3):292–303.
28 Ou-Yang C, Wulandari CP, Hariadi RAR, Wang H-C, Chen C. Applying sequential pattern mining to investigate cerebrovascular health outpatients’ re-visit patterns. PeerJ. 2018;6:e5183.
29 Grant MJ, Booth A. A typology of reviews: An analysis of 14 review types and associated methodologies. Health Info Libr J. 2009;26(2):91–108.
30 Grisold W, Galvin R, Lisnic V, Lopes Lima J, Mueller E, Oberndorfer S, et al. One Europe, one neurologist? Eur J Neurol. 2007;14(3):241–7.